Search
for

    Glossary Rituximab

    monoclonal antibody targeting CD20 protein on B-cells

    Rituximab, also known as Rituxan, is a monoclonal antibody used to treat certain autoimmune diseases and types of cancer, such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia. It works by targeting and binding to the CD20 protein found on the surface of B-cells, leading to their destruction, which helps in reducing the abnormal immune response or cancerous growth.

    Research 10 of 341

    1. Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome Pediatric Nephrology · 2015 · 39 citations
    2. Severe steroid-dependent idiopathic angioedema with response to rituximab Annals of Allergy Asthma & Immunology · 2011 · 16 citations
    3. Rituximab for Bone Lymphoma Annals of Internal Medicine · 2001 · 5 citations
    4. Alopecia Universalis in a Multiple Sclerosis Patient After Switching From Rituximab to Ocrelizumab: A Case Report International Journal of Rheumatic Diseases · 2024 · 2 citations
    5. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis Clinical Cosmetic and Investigational Dermatology · 2026
    6. Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis SHILAP Revista de lepidopterología · 2026
    7. Use of Rituximab for Dermatomyositis Over Conventional Therapy: A Case Report Case Reports in Rheumatology · 2026
    8. EP06 Successful treatment of alopecia universalis with rituximab therapy Rheumatology · 2020
    9. Efficacy of Rituximab in Successful Management of Refractory Juvenile Systemic Lupus Erythematosus Complicated with Macrophage Activation Syndrome: A Case Report with Literature Overview Indian Journal of Dermatology · 2026
    10. Reply to “Regarding the risk factors of rituximab‐induced thrombocytopenia in patients with autoimmune bullous diseases” The Journal of Dermatology · 2024
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →